
PMC:3333881 / 45613-45803
Annnotations
pmc-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20866 | 0-2 | IN | denotes | In |
T20867 | 3-7 | DT | denotes | this |
T20868 | 8-16 | NN | denotes | scenario |
T20869 | 16-17 | -COMMA- | denotes | , |
T20870 | 18-28 | NN | denotes | inhibition |
T20871 | 29-31 | IN | denotes | of |
T20872 | 32-37 | NN | denotes | NF-κB |
T20873 | 38-46 | NN | denotes | activity |
T20874 | 47-52 | MD | denotes | could |
T20875 | 53-57 | VB | denotes | lead |
T20876 | 58-60 | TO | denotes | to |
T20877 | 61-62 | DT | denotes | a |
T20878 | 63-74 | JJ | denotes | therapeutic |
T20879 | 75-83 | NN | denotes | strategy |
T20880 | 84-87 | IN | denotes | for |
T20881 | 88-101 | VB | denotes | counteracting |
T20882 | 102-105 | DT | denotes | the |
T20883 | 106-114 | JJ | denotes | abnormal |
T20884 | 115-125 | NN | denotes | production |
T20885 | 126-128 | IN | denotes | of |
T20886 | 129-145 | JJ | denotes | pro-inflammatory |
T20887 | 146-155 | NN | denotes | cytokines |
T20888 | 156-159 | CC | denotes | and |
T20889 | 160-170 | NN | denotes | chemokines |
T20890 | 171-173 | IN | denotes | in |
T20891 | 174-179 | NN | denotes | HIV-1 |
T20892 | 180-189 | NN | denotes | infection |
R16834 | T20868 | T20866 | arg2Of | scenario,In |
R16835 | T20868 | T20867 | arg1Of | scenario,this |
R16836 | T20870 | T20871 | arg1Of | inhibition,of |
R16837 | T20870 | T20874 | arg1Of | inhibition,could |
R16838 | T20870 | T20875 | arg1Of | inhibition,lead |
R16839 | T20873 | T20871 | arg2Of | activity,of |
R16840 | T20873 | T20872 | arg1Of | activity,NF-κB |
R16841 | T20875 | T20866 | arg1Of | lead,In |
R16842 | T20875 | T20869 | arg1Of | lead,"," |
R16843 | T20875 | T20874 | arg2Of | lead,could |
R16844 | T20875 | T20876 | arg1Of | lead,to |
R16845 | T20879 | T20876 | arg2Of | strategy,to |
R16846 | T20879 | T20877 | arg1Of | strategy,a |
R16847 | T20879 | T20878 | arg1Of | strategy,therapeutic |
R16848 | T20879 | T20880 | arg1Of | strategy,for |
R16849 | T20881 | T20880 | arg2Of | counteracting,for |
R16850 | T20884 | T20881 | arg2Of | production,counteracting |
R16851 | T20884 | T20882 | arg1Of | production,the |
R16852 | T20884 | T20883 | arg1Of | production,abnormal |
R16853 | T20884 | T20885 | arg1Of | production,of |
R16854 | T20884 | T20890 | arg1Of | production,in |
R16855 | T20887 | T20886 | arg1Of | cytokines,pro-inflammatory |
R16856 | T20887 | T20888 | arg1Of | cytokines,and |
R16857 | T20888 | T20885 | arg2Of | and,of |
R16858 | T20889 | T20888 | arg2Of | chemokines,and |
R16859 | T20892 | T20890 | arg2Of | infection,in |
R16860 | T20892 | T20891 | arg1Of | infection,HIV-1 |
bionlp-st-ge-2016-spacy-parsed
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22233 | 0-2 | IN | denotes | In |
T22234 | 3-7 | DT | denotes | this |
T22235 | 8-16 | NN | denotes | scenario |
T22236 | 16-17 | , | denotes | , |
T22237 | 18-28 | NN | denotes | inhibition |
T22238 | 29-31 | IN | denotes | of |
T22239 | 32-37 | JJ | denotes | NF-κB |
T22240 | 38-46 | NN | denotes | activity |
T22241 | 47-52 | MD | denotes | could |
T22242 | 53-57 | VB | denotes | lead |
T22243 | 58-60 | TO | denotes | to |
T22244 | 61-62 | DT | denotes | a |
T22245 | 63-74 | JJ | denotes | therapeutic |
T22246 | 75-83 | NN | denotes | strategy |
T22247 | 84-87 | IN | denotes | for |
T22248 | 88-101 | VBG | denotes | counteracting |
T22249 | 102-105 | DT | denotes | the |
T22250 | 106-114 | JJ | denotes | abnormal |
T22251 | 115-125 | NN | denotes | production |
T22252 | 126-128 | IN | denotes | of |
T22253 | 129-145 | JJ | denotes | pro-inflammatory |
T22254 | 146-155 | NNS | denotes | cytokines |
T22255 | 156-159 | CC | denotes | and |
T22256 | 160-170 | NNS | denotes | chemokines |
T22257 | 171-173 | IN | denotes | in |
T22258 | 174-179 | JJ | denotes | HIV-1 |
T22259 | 180-189 | NN | denotes | infection |
T22260 | 189-190 | . | denotes | . |
R17924 | T22233 | T22242 | prep | In,lead |
R17925 | T22234 | T22235 | det | this,scenario |
R17926 | T22235 | T22233 | pobj | scenario,In |
R17927 | T22236 | T22242 | punct | ",",lead |
R17928 | T22237 | T22242 | nsubj | inhibition,lead |
R17929 | T22238 | T22237 | prep | of,inhibition |
R17930 | T22239 | T22240 | amod | NF-κB,activity |
R17931 | T22240 | T22238 | pobj | activity,of |
R17932 | T22241 | T22242 | aux | could,lead |
R17933 | T22242 | T22242 | ROOT | lead,lead |
R17934 | T22243 | T22242 | prep | to,lead |
R17935 | T22244 | T22246 | det | a,strategy |
R17936 | T22245 | T22246 | amod | therapeutic,strategy |
R17937 | T22246 | T22243 | pobj | strategy,to |
R17938 | T22247 | T22246 | prep | for,strategy |
R17939 | T22248 | T22247 | pcomp | counteracting,for |
R17940 | T22249 | T22251 | det | the,production |
R17941 | T22250 | T22251 | amod | abnormal,production |
R17942 | T22251 | T22248 | dobj | production,counteracting |
R17943 | T22252 | T22251 | prep | of,production |
R17944 | T22253 | T22254 | amod | pro-inflammatory,cytokines |
R17945 | T22254 | T22252 | pobj | cytokines,of |
R17946 | T22255 | T22254 | cc | and,cytokines |
R17947 | T22256 | T22254 | conj | chemokines,cytokines |
R17948 | T22257 | T22254 | prep | in,cytokines |
R17949 | T22258 | T22259 | amod | HIV-1,infection |
R17950 | T22259 | T22257 | pobj | infection,in |
R17951 | T22260 | T22242 | punct | .,lead |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19908 | 0-190 | Sentence | denotes | In this scenario, inhibition of NF-κB activity could lead to a therapeutic strategy for counteracting the abnormal production of pro-inflammatory cytokines and chemokines in HIV-1 infection. |
T265 | 0-190 | Sentence | denotes | In this scenario, inhibition of NF-κB activity could lead to a therapeutic strategy for counteracting the abnormal production of pro-inflammatory cytokines and chemokines in HIV-1 infection. |
bionlp-st-ge-2016-reference-tees
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23851 | 32-37 | Protein | denotes | NF-κB |
T23852 | 18-28 | Negative_regulation | denotes | inhibition |
R19034 | T23851 | T23852 | themeOf | NF-κB,inhibition |